MGRX חוב כולל להון MangoRx

Mangoceuticals, Inc. (MGRX) is developing a recognizable digital brand in the US, offering private medical consultations for men. However, fierce competition for customers with industry behemoths is forcing the company to lower prices, which is weighing on profitability. The asset's market dynamics reflect a total debt-to-equity ratio of 0.03. Meanwhile, the business avoids direct conflicts, although disruptions in global raw material logistics could indirectly reduce software yields.

This ratio compares total liabilities to net assets, determining the company's reliance on debt financing and the risk of insolvency. By analyzing the leverage of equity, an investor assesses the stability of Mangoceuticals, Inc. (MGRX) while scaling its telemedicine and men's health subscription service, where the balance between debt and equity critically impacts the business's operational flexibility.